bioAffinity raises $4M via private placement of 8.46M shares and warrants

bioAffinity Technologies, Inc.

Gross proceeds ~$4.0M; net proceeds ~$3.6M after fees; closed Aug 14, 2026.
Sold 8,462,027 shares (or pre-funded warrants) at $0.4727 combined with two warrants; pre-funded at $0.4657.
Warrants exercisable at $0.4727, expire in 5 years, subject to stockholder approval; pre-funded at $0.007.
Placement agent WallachBeth Capital gets 7.5% cash fee and warrants for 253,861 shares.
Proceeds for working capital and general corporate purposes; resale registration due within 15 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.